NZ237904A - Gastric sustained release compositions comprising triclosan - Google Patents

Gastric sustained release compositions comprising triclosan Download PDF

Info

Publication number
NZ237904A
NZ237904A NZ237904A NZ23790491A NZ237904A NZ 237904 A NZ237904 A NZ 237904A NZ 237904 A NZ237904 A NZ 237904A NZ 23790491 A NZ23790491 A NZ 23790491A NZ 237904 A NZ237904 A NZ 237904A
Authority
NZ
New Zealand
Prior art keywords
triclosan
sustained release
medicaments
release compositions
spheroids
Prior art date
Application number
NZ237904A
Other languages
English (en)
Inventor
Peter William Dettmar
John Gareth Lloyd-Jones
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of NZ237904A publication Critical patent/NZ237904A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ237904A 1990-05-03 1991-04-22 Gastric sustained release compositions comprising triclosan NZ237904A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909010039A GB9010039D0 (en) 1990-05-03 1990-05-03 Medicament preparation

Publications (1)

Publication Number Publication Date
NZ237904A true NZ237904A (en) 1993-06-25

Family

ID=10675466

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ237904A NZ237904A (en) 1990-05-03 1991-04-22 Gastric sustained release compositions comprising triclosan

Country Status (11)

Country Link
US (1) US5286492A (fr)
EP (1) EP0455475B1 (fr)
AT (1) ATE124626T1 (fr)
AU (1) AU645555B2 (fr)
CA (1) CA2041400C (fr)
DE (1) DE69110969T2 (fr)
DK (1) DK0455475T3 (fr)
GB (2) GB9010039D0 (fr)
IE (1) IE65826B1 (fr)
NZ (1) NZ237904A (fr)
ZA (1) ZA912933B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440395B1 (en) 1992-06-22 2002-08-27 Barry M. Libin Antiplaque mouth rinse
SE9201930D0 (sv) * 1992-06-24 1992-06-24 Astra Ab Gastric antibacterial treatment
EP0697861B1 (fr) * 1993-05-13 1998-08-26 Unilever N.V. Compositions orales contenant du triclosan, destinees au traitement des ulceres aphteux
AU7833194A (en) * 1993-09-20 1995-04-10 Procter & Gamble Company, The Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) * 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
WO1995031199A1 (fr) * 1994-05-11 1995-11-23 P.N. Gerolymatos S.A. Utilisation de clioquinol dans le traitement d'infections provoquees par helicobacter, y compris h. pylori et de maladies apparentees
US5498528A (en) * 1994-06-10 1996-03-12 King; Wing Detection of helicobacter pylori
GB9505032D0 (en) * 1995-03-13 1995-05-03 Westminster Lab Ltd Improvements in or relating to organic compositions
CA2193104A1 (fr) * 1994-06-29 1996-01-11 Peter William Dettmar Compositions pharmaceutiques renfermant du triclosan ou ses derives et de l'edta ou de l'egta
US5389386A (en) * 1994-06-30 1995-02-14 Church & Dwight Co., Inc. Method of controlling fungal disease in cultivated plants
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
WO1997045103A1 (fr) * 1996-05-31 1997-12-04 R & D Ventures, Inc. Compositions de pastilles effervescentes pour le bain
AU720643B2 (en) * 1996-08-13 2000-06-08 P.N. Gerolymatos S.A. Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of Alzheimer's disease
GB9708772D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
US6395307B1 (en) * 1997-04-30 2002-05-28 Reckitt Benckiser (Uk) Limited Pourable alginate compositions
US6108850A (en) * 1997-06-03 2000-08-29 Mclaughlin; Gerald Accelerated method and instrumentation for whitening teeth
US5980914A (en) * 1997-08-22 1999-11-09 P.N. Gerolymatos S.A. Clioquinol for the treatment of Parkinson's disease
US5994323A (en) * 1997-12-31 1999-11-30 P.N. Gerolymatos S.A. Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof
GB9809347D0 (en) * 1998-05-05 1998-07-01 Reckitt & Colmann Prod Ltd Compositions
ES2249816T3 (es) * 1998-07-30 2006-04-01 Merck Sante Pastilla para la liberacion extendida de un farmaco en el estomago.
US5945089A (en) * 1998-11-05 1999-08-31 I-Dent International Corporation Method of treating mucositis
IN190017B (fr) * 1999-01-25 2003-05-31 Panacea Biotech Ltd
US6576625B2 (en) 2001-03-16 2003-06-10 Panacea Biotic Limited Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
KR100753471B1 (ko) * 2001-09-06 2007-08-31 주식회사 엘지생활건강 트리클로산을 포함하는 마이크로 캡슐의 제조방법
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
CN1638804A (zh) * 2002-03-04 2005-07-13 美德阿利克斯株式会社 在生物体内相转移的液态基质以及液态口服制剂
CN1787750B (zh) * 2003-06-18 2010-12-01 努特里希亚公司 热液纤维产物
US20050202084A1 (en) * 2003-07-10 2005-09-15 Prasad Adusumilli Pharmaceutical compositions
WO2005018613A1 (fr) * 2003-08-26 2005-03-03 Mandapro Ag Comprimes pour l'administration par voie orale de principes actifs pharmaceutiques
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
EP1931222B1 (fr) * 2005-10-05 2012-02-15 FMC Biopolymer AS Compositions de gelification et procedes
DE102006062111A1 (de) 2006-12-23 2008-06-26 Farco-Pharma Gmbh Zusammensetzung, insbesondere für das Blockieren von Kathetern
JP7518162B2 (ja) * 2019-10-31 2024-07-17 ザ プロクター アンド ギャンブル カンパニー 抗菌粒子

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH406127A (de) * 1963-02-22 1966-08-15 Geigy Ag J R Verfahren zum antimikrobiellen Ausrüsten von Textilien
JPS5157813A (en) * 1974-11-14 1976-05-20 Sankyo Co Ll dooba mataha sonojudotaiseizaino seiho
GB2015875B (en) * 1978-02-24 1982-10-20 Novex Foreign Trade Co Ltd Solid oral pharaceutical product with increased efficacy and predetermined steady state of solubility
WO1986005981A1 (fr) * 1985-04-18 1986-10-23 Borody Thomas J Traitement de la dyspepsie non ulcereuse avec des sels de bismuth
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
ATE79261T1 (de) * 1985-06-13 1992-08-15 Barry James M D Marshall Verfahren zur behandlung von magen-darmstoerungen.
ATE135582T1 (de) * 1985-06-13 1996-04-15 Barry James Marshall Verfahren und zusammensetzungen zur behandlung von gastrointestinalen störungen
GB8526093D0 (en) * 1985-10-22 1985-11-27 Beecham Group Plc Composition
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
JP2733849B2 (ja) * 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス 胃腸障害治療のための改良された方法

Also Published As

Publication number Publication date
GB9109439D0 (en) 1991-06-26
EP0455475A3 (en) 1992-02-26
EP0455475B1 (fr) 1995-07-05
ZA912933B (en) 1992-01-29
HK1007963A1 (en) 1999-04-30
DE69110969T2 (de) 1995-11-16
CA2041400C (fr) 2001-04-24
GB2243549B (en) 1994-05-04
IE911483A1 (en) 1991-11-06
CA2041400A1 (fr) 1991-11-04
IE65826B1 (en) 1995-11-15
EP0455475A2 (fr) 1991-11-06
DE69110969D1 (de) 1995-08-10
GB2243549A (en) 1991-11-06
GB9010039D0 (en) 1990-06-27
ATE124626T1 (de) 1995-07-15
AU7596891A (en) 1991-11-07
DK0455475T3 (da) 1995-10-30
US5286492A (en) 1994-02-15
AU645555B2 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
NZ237904A (en) Gastric sustained release compositions comprising triclosan
GR3001284T3 (en) Pharmaceutical composition containing ibuprofen and aluminium hydroxide
PL341466A1 (en) Instantaneously spreading dised pharmacological preparation and method of forming granules
AU3731699A (en) Orally disintegrable tablets
IL110190A (en) Magnesium omeprazole with crystallinity higher than 70% process for its preparation and its use in the manufacture of medicaments for inhibiting gastric acid secretion and for obtaining gastric mucosa protective activity
MY125662A (en) Pharmaceutical formulations containing darifenacin
CZ141995A3 (en) Effervescent pharmaceutical preparation containing ibuprofen and process for preparing thereof
MY127350A (en) Flash-melt oral dose formulations
IL91949A (en) Dispersible formulation containing the free acid form of diclofenac
CA2383212A1 (fr) Dosage oral a liberation regulee destine a l'administration orale
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
JP2004231546A (ja) 解熱鎮痛用組成物
DE2960927D1 (en) N1-benzoyl-n2-phenyl-1,3-diaminopropane-2-ols and their salts, process for their preparation and medicaments containing them
JPS57114518A (en) Hypotensive agent
JPS5759808A (en) Remedy and preventive for digestive ulcer
RU96123569A (ru) Лекарственный препарат
JPS57114519A (en) Antiarteriosclerotic agent
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
JPS57112329A (en) Drug against arterioschlerosis comprising 2,3- dihydroxypropyl ester of n-(7-chloro-4-quinolyl) anthranillic acid
JPS55133313A (en) Cholesterol-lowering agent